Effect of dabigatran or rivaroxaban on activated clotting times during atrial ablation procedures in patients with renal impairment

Trial Profile

Effect of dabigatran or rivaroxaban on activated clotting times during atrial ablation procedures in patients with renal impairment

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Feb 2017

At a glance

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top